FDA approval of first Ebola vaccine marks speedy win for Merck

FDA approved Merck’s Ervebo -- the first Ebola vaccine approved in the U.S. -- three months ahead of its

Read the full 194 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE